Juan I. Young
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Juan I. Young has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Matías Alvarez-Saavedra
Centro de Estudios Científicos, Valdivia 5110246 , Chile
2 shared publications- Mauricio Alejandro Saez
Laboratorio de Investigación en Salud de Precisión, Departamento de Procesos Diagnósticos y Evaluación, Facultad de Ciencias de la Salud, Universidad Católica de Temuco, Temuco, Chile
2 shared publications Alexandra Saona
Centro de Estudios Científicos, Valdivia 5110246 , Chile 2 Universidad Austral de Chile , Valdivia 905-9100 , Chile
1 shared publication- Bredford Kerr
Facultad de Ciencias, Centro de Biología Celular y Biomedicina (CEBICEM), Universidad San Sebastián, Huechuraba, Santiago, 8580704, Chile.
1 shared publication Dongcheul Kang
Howard Hughes Medical Institute , Chevy Chase, MD , USA
1 shared publication- Huda Yahya Zoghbi
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX
1 shared publication
Latest Publications
- Open Access
- 4 March 2008
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 17 (12) , 1707-1717
Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice
MeCP2 is an abundant protein that binds to methylated cytosine residues in DNA and regulates transcription. Mutations in MECP2 cause Rett syndrome, a severe neurological disorder that affects approximately 1:10 000 females. Mice lacking MeCP2 have been generated and constitute important models of Rett syndrome. However, it is yet unclear whether certain physiological events are sensitive to a decrease, rather than a complete lack of MeCP2. Here we report that a Mecp2 floxed allele (Mecp2lox) that was generated to allow conditional mutagenesis behaves as a hypomorph and the corresponding mutant mice exhibit phenotypical alterations including body weight gain, motor abnormalities and altered social behavior. Our data reinforce the view that the central nervous system is extremely sensitive to MeCP2 expression levels and suggest that the 3′-UTR of Mecp2 might contain important elements that contribute to the regulation of its stability or processing.
- 4 March 2008
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 17 (12) , 1707-1717
Open AccessDefective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice
MeCP2 is an abundant protein that binds to methylated cytosine residues in DNA and regulates transcription. Mutations in MECP2 cause Rett syndrome, a severe neurological disorder that affects approximately 1:10 000 females. Mice lacking MeCP2 have been generated and constitute important models of Rett syndrome. However, it is yet unclear whether certain physiological events are sensitive to a decrease, rather than a complete lack of MeCP2. Here we report that a Mecp2 floxed allele (Mecp2lox) that was generated to allow conditional mutagenesis behaves as a hypomorph and the corresponding mutant mice exhibit phenotypical alterations including body weight gain, motor abnormalities and altered social behavior. Our data reinforce the view that the central nervous system is extremely sensitive to MeCP2 expression levels and suggest that the 3′-UTR of Mecp2 might contain important elements that contribute to the regulation of its stability or processing.
- Open Access
- 17 July 2007
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 16 (19) , 2315-2325
Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis
Rett syndrome (RTT), a leading cause of mental retardation with autistic features in females, is caused by mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2). RTT is characterized by a diverse set of neurological features that includes cognitive, motor, behavioral and autonomic disturbances. The diverse features suggest that specific neurons contribute to particular phenotypes and raise the question whether restoring MeCP2 function in a cell-specific manner will rescue some of the phenotypes seen in RTT. To address this, we generated transgenic mice expressing inducible MeCP2 under the control of the brain-specific promoters calcium/calmodulin-dependent protein kinase II (CamKII) or neuron-specific enolase (Eno2) and bred them onto mouse models lacking functional MeCP2. Expression of normal MeCP2 in either CamKII or Eno2 distribution was unable to prevent the appearance of most of the phenotypes of the RTT mouse models. These results suggest that most RTT phenotypes are caused either by disruption of complex neural networks involving neurons throughout the brain or by disruption of the function of specific neurons outside of the broad CamKII or Eno2 distribution.
- 17 July 2007
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 16 (19) , 2315-2325
Open AccessCell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis
Rett syndrome (RTT), a leading cause of mental retardation with autistic features in females, is caused by mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2). RTT is characterized by a diverse set of neurological features that includes cognitive, motor, behavioral and autonomic disturbances. The diverse features suggest that specific neurons contribute to particular phenotypes and raise the question whether restoring MeCP2 function in a cell-specific manner will rescue some of the phenotypes seen in RTT. To address this, we generated transgenic mice expressing inducible MeCP2 under the control of the brain-specific promoters calcium/calmodulin-dependent protein kinase II (CamKII) or neuron-specific enolase (Eno2) and bred them onto mouse models lacking functional MeCP2. Expression of normal MeCP2 in either CamKII or Eno2 distribution was unable to prevent the appearance of most of the phenotypes of the RTT mouse models. These results suggest that most RTT phenotypes are caused either by disruption of complex neural networks involving neurons throughout the brain or by disruption of the function of specific neurons outside of the broad CamKII or Eno2 distribution.